in conclusion , although the three type i antiarrhythmic agents tested may all adversely affect left ventricular function in patients with heart failure , encainide and tocainide are more likely than procainamide to cause hemodynamic and clinical deterioration .
C0003195
antiarrhythmic agents
C0033216
procainamide